News Daily News Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes Shelley Wood September 28, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News Un Estudio Revela un Sorprendente Rango de Riesgo Post-IAM entre Pacientes con Diabetes L.A. McKeown May 26, 2016
News Daily News Study Shows Surprising Range of Risk After Acute MI Among Patients With Diabetes L.A. McKeown May 26, 2016
Presentation Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus Presenter: Suzanne V. Arnold May 25, 2016
News Daily News A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG Yael L. Maxwell May 13, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Industry News Victoza® Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial March 06, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Daily News High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease Todd Neale August 17, 2015
News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015
News Daily News ‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes Caitlin E. Cox May 08, 2015